Korea ‘Guide’ Program To Speed Select Innovative Products To Market

Part Of Regulatory Science Push

In an ongoing effort to accelerate the commercialization of select innovative drugs and medical devices, Korea’s MFDS is launching a new program for certain products that will receive regular regulatory consultations until they reach the approval stage.

shortcut
Korea's Ongoing Efforts To Accelerate Market Entry Of Innovative Products (Shutterstock)

More from South Korea

More from R&D